연구성과로 돌아가기
2021 연구자 정보 (887 / 1146)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Panneerselvam, Periyasamy (Panneerselvam, P) |
교신저자 | ICAR Natl Rice Res Inst, Dept Soil Sci & Microbiol, Crop Prod Div, Cuttack 753006, Odisha, India |
AAD-3311-2022 Panneerselvam, Periyasamy |
0000-0001-7144-2947 Panneerselvam, Periyasamy |
[JCR상위 48.3] Arbuscular mycorrhizal symbiosis: plant growth improvement and induction of resistance under stressful conditions | SCIE | 48.3 | PLANT SCIENCES | panneerccri@rediffmail.com;pkdmvu@gmail.com; | |
|
Park, Ju-Yeon (Park, JY) |
Ewha Womans Univ, Dept Food Sci & Engn, Seoul 03760, South Korea |
MYR-6366-2025 Park, Ju-Yeon |
|
[JCR상위 48.3] Microbial inactivation in fresh and minimally processed foods by intense pulsed light (IPL) treatment | SCIE | 48.3 | FOOD SCIENCE & TECHNOLOGY | piatop@hanmail.net;wnwn1995@naver.com;mschung@ewha.ac.kr;cic@knu.ac.kr; | ||
|
Pellegrini, Marika (Pellegrini, M) |
Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy |
AAA-9802-2020 Pellegrini, Marika |
0000-0002-0073-9935 Pellegrini, Marika |
[JCR상위 48.3] Arbuscular mycorrhizal symbiosis: plant growth improvement and induction of resistance under stressful conditions | SCIE | 48.3 | PLANT SCIENCES | panneerccri@rediffmail.com;pkdmvu@gmail.com; | ||
|
Ahn, Hee Kyung (Ahn, HK) |
Gachon Univ, Gil Med Ctr, Coll Med, Incheon, South Korea |
|
|
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; | ||
|
Ahn, Myung-Ju (Ahn, MJ) |
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; | ||
|
Choi, Su Kyung (Choi, SK) |
Hlth Insurance Review & Assessment Pharmaceut Ben, Wonju, South Korea |
|
|
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; | ||
|
Choi, Yoon Hee (Choi, YH) |
Dongnam Inst Radiol & Med Sci, Busan, South Korea |
AAK-5172-2021 choi, Yoon |
|
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; | ||
|
Han, Ji-Youn (Han, JY) |
Natl Canc Ctr, Res Inst & Hosp, Ctr Lung Canc, Goyang, South Korea |
|
|
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; | ||
|
Hong, Min Hee (Hong, MH) |
Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea |
|
0000-0003-3490-2195 Hong, Min Hee |
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; | ||
|
Kang, Jin Hyoung (Kang, JH) |
교신저자 | Catholic Univ, Seoul St Marys Hosp, Dept Med Oncol, 222 Banpo Daero, Seoul 06591, South Korea |
KYQ-2256-2024 Kang, Jin Hyoung |
|
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; | |
|
Kim, Cheol Hyeon (Kim, CH) |
Korea Canc Ctr Hosp, Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; | ||
|
Kim, Jong Hwan (Kim, JH) |
Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Inst Innovat Canc Res, Coll Med, Seoul 05505, South Korea Korea Res Inst Biosci & Biotechnol, Genome Editing Res Ctr, Personalized Genom Med Res Ctr, 52 Eoeun Dong, Daejeon 34141, South Korea |
|
|
[JCR상위 48.4] Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria | SCIE | 48.4 | ONCOLOGY | jckim@amc.seoul.kr;kimsy@kribb.re.kr; | ||
|
Kim, Sang-We (Kim, SW) |
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Med Oncol, Seoul, South Korea |
AAN-9079-2021 Kim, Tae-Hee |
|
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; | ||
|
Kwon, Yi Hong (Kwon, YH) |
Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Inst Innovat Canc Res, Coll Med, Seoul 05505, South Korea |
J-5452-2012 Bin Kim, Hong |
|
[JCR상위 48.4] Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria | SCIE | 48.4 | ONCOLOGY | jckim@amc.seoul.kr;kimsy@kribb.re.kr; | ||
|
Lee, Jong-Seok (Lee, JS) |
Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea |
|
|
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | SCIE | 48.4 | ONCOLOGY | oncologykang@naver.com; |
페이지 이동: